| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/2010 | US7754872 Liposomal phosphodiester, phophorothioate, and p-ethoxy oligonucleotides |
| 07/13/2010 | US7754857 Human p51 genes and gene products thereof |
| 07/13/2010 | US7754856 Human sodium-dependent bile acid transporter proteins |
| 07/13/2010 | US7754855 comprising a full-length human erythropoietin protein joined without an intervening peptide linker to a human immunoglobulin domain; making fusion proteins comprising a cytokine or growth factor fused to an immunoglobulin domain; treating deficient hematocrit; purification |
| 07/13/2010 | US7754854 Sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution |
| 07/13/2010 | US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 07/13/2010 | US7754852 Natriuretic polypeptides |
| 07/13/2010 | US7754851 wound closure or coverage systems, comprising employing the recombinant spider silk protein; artificial cartilage, tendon materials, automotive parts or parts used in the aircraft construction, which comprise the protein |
| 07/13/2010 | US7754850 Chimeric disintegrin domain |
| 07/13/2010 | US7754734 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/13/2010 | US7754692 Treating retinopathy both of diabetes and prematurity, or tumor growth |
| 07/13/2010 | US7754691 Linear melanocortin receptor-specific peptides for cachexia |
| 07/13/2010 | US7754690 Method of using retro inverso peptides derived from leukemia inhibitory factor |
| 07/13/2010 | US7754689 Finger-1 peptide analogs of the TGF-β superfamily |
| 07/13/2010 | US7754688 Methods of using retro-inverso peptides derived from interleukin-6 |
| 07/13/2010 | US7754687 administering isolated Prothymosin alpha molecule; retrovirus, lentivirus, hepatitis virus, human immunodeficiency virus |
| 07/13/2010 | US7754686 fibroblast growth factor (FGF); lyophilization; storage stability |
| 07/13/2010 | US7754685 Cyclosporin derivatives; immunomodulators |
| 07/13/2010 | US7754684 Macromolecular platinum chelates |
| 07/13/2010 | US7754683 pharmacokinetics; sustained release; cost efficiency; industrial scale |
| 07/13/2010 | US7754682 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 07/13/2010 | US7754681 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 07/13/2010 | US7754679 Pharmaceutical compositions for the administration of aptamers |
| 07/13/2010 | US7754678 fusion proteins; drug delivery |
| 07/13/2010 | US7754676 Cancer and viral infections vaccines; increased immunogenicity |
| 07/13/2010 | US7754461 Large-scale production of human serum butyrylcholinesterase as a bioscavenger |
| 07/13/2010 | US7754459 having an amino acid sequence which has a functional NAD+ binding domain and no PARP zinc finger sequence motifs |
| 07/13/2010 | US7754449 Human papilloma virus treatment |
| 07/13/2010 | US7754420 genetic engineering of a cyanovirin; gene therapy; exogenous gene expression; use alone or in combination with antiviral agents such as AZT; AIDS therapy |
| 07/13/2010 | US7754418 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/13/2010 | US7754253 Botulinum toxin for the treatment of reduction of hair growth |
| 07/13/2010 | US7754228 Cytotoxic T-cell epitopes from Chlamydia |
| 07/13/2010 | US7754220 Continuously administering to a male animal a polypeptide havingan amino acid sequence to promote the activity of Metastin, (kisspeptin-54), an endogenous ligand for G protein-coupled receptor; promoters of fertility, ovulation; treating hormone-sensitive cancers; endometriosis; drug screening |
| 07/13/2010 | US7754219 by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen |
| 07/13/2010 | US7754217 HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/13/2010 | US7754214 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 07/13/2010 | US7754212 Contraceptives based on SP22 and SP22 antibodies |
| 07/13/2010 | US7754208 That feature a binding domain for a cognate structure such as an antigen, a counterreceptor or the like, a wild-type IgG1, IGA or IgE hinge region polypeptide or a mutant IgG1 hinge region polypeptide |
| 07/13/2010 | US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient |
| 07/13/2010 | CA2563433C Methods and compositions for control of fetal growth via modulation of relaxin |
| 07/13/2010 | CA2538124C Biological active coating components, coatings, and coated surfaces |
| 07/13/2010 | CA2474734C Thermostable taq polymerase fragment |
| 07/13/2010 | CA2423488C Thermogelling biodegradable aqueous polymer solution |
| 07/13/2010 | CA2420992C Soluble zalpha11 cytokine receptors |
| 07/13/2010 | CA2420350C Membrane penetrating peptides and uses thereof |
| 07/13/2010 | CA2381439C Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 07/13/2010 | CA2347713C Contulakin-g, analogs thereof and uses therefor |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |
| 07/13/2010 | CA2307954C Enzyme-medicated modification of fibrin for tissue engineering |
| 07/13/2010 | CA2286873C Dendritic cell hybrids |
| 07/13/2010 | CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 07/13/2010 | CA2259724C Monoclonal antibody which is specific for activated coagulation factor vii, and its use |
| 07/13/2010 | CA2245242C Purified sr-p70 protein |
| 07/13/2010 | CA2183564C Methods for altering fertility |
| 07/13/2010 | CA2176742C Composition for the in vivo production of therapeutic products |
| 07/08/2010 | WO2010078469A2 Sand fly salivary proteins as novel factor xa inhibitors and methods of use |
| 07/08/2010 | WO2010078466A2 Sand fly salivary proteins with anti-complement activity and methods of their use |
| 07/08/2010 | WO2010078458A1 Dominant negative wnt2 compositions and methods of use |
| 07/08/2010 | WO2010078325A2 Natriuretic polypeptides for reducing or preventing restenosis |
| 07/08/2010 | WO2010078285A2 Pharmaceutical compositions and methods of treating neurological insults |
| 07/08/2010 | WO2010078042A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/08/2010 | WO2010077693A2 Method for identifying agents for inhibiting cell motility and invasiveness |
| 07/08/2010 | WO2010077642A1 Method of modulating hsf-1 |
| 07/08/2010 | WO2010077364A2 Stroke-generated angiogenesis enhancers and uses thereof |
| 07/08/2010 | WO2010077339A2 β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 07/08/2010 | WO2010077260A1 Pegylated hemoglobins stabilized at valine-1(alpha), methods of preparation and uses thereof |
| 07/08/2010 | WO2010077201A1 A composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart -beating potential organ donor |
| 07/08/2010 | WO2010077200A1 A composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor. |
| 07/08/2010 | WO2010077154A1 A method of producing a novel opioid peptide |
| 07/08/2010 | WO2010077093A2 Composition for promoting hair growth or preventing hair loss comprising erythropoietin |
| 07/08/2010 | WO2010076896A1 Prophylactic/therapeutic agent for cancer |
| 07/08/2010 | WO2010076887A1 Predictive biomarkers useful for cancer therapy mediated by a wee1 inhibitor |
| 07/08/2010 | WO2010076851A1 Therapeutic/prophylactic agent for infections which relies on regulation of il-17a/il-17f |
| 07/08/2010 | WO2010076583A1 A variant of mite allergen and uses thereof |
| 07/08/2010 | WO2010076517A1 Erythrocytes containing factor viii, preparation and uses |
| 07/08/2010 | WO2010076339A1 Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants |
| 07/08/2010 | WO2010076329A1 Derivatives of cyclosporin a |
| 07/08/2010 | WO2010075824A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes |
| 07/08/2010 | WO2010075770A1 A recombinant fusion protein, the preparation method and use thereof |
| 07/08/2010 | WO2010075635A1 Combination therapies using nap |
| 07/08/2010 | WO2010075611A1 Composition comprising proanthocyanidin, proteolytic enzyme and aloe vera/agave species substance |
| 07/08/2010 | WO2010054141A8 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same |
| 07/08/2010 | WO2010052144A3 Neuropeptide-2-receptor (y-2r) agonists and uses thereof |
| 07/08/2010 | WO2010048365A3 Therapeutic peptide bioconjugates |
| 07/08/2010 | WO2010039510A3 Use of syndyphalin-33 (sd-33; try-dmet(o)-gly-methylphenylethylamide) as a therapeutic agent to enhance the health and well-being of newly-weaned animals |
| 07/08/2010 | WO2010019698A3 Inhibition of calicivirus (norovirus) |
| 07/08/2010 | WO2009024631A9 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia |
| 07/08/2010 | US20100174222 Method and apparatus for acne treatment using low intensity light therapy |
| 07/08/2010 | US20100174056 Recombinant tumor specific antibody and use thereof |
| 07/08/2010 | US20100173980 Antiviral oligonucleotides targeting rsv |
| 07/08/2010 | US20100173947 New Indications for Direct Thrombin Inhibitors |
| 07/08/2010 | US20100173868 Composition and method for healing tissues |
| 07/08/2010 | US20100173852 USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES |
| 07/08/2010 | US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 07/08/2010 | US20100173850 Improved Peptide Composition |
| 07/08/2010 | US20100173849 Neo-tryptophan |
| 07/08/2010 | US20100173848 Methods of inhibiting chemokine binding to chemokines receptors |
| 07/08/2010 | US20100173847 Tfpi inhibitors and methods of use |
| 07/08/2010 | US20100173846 Magnesium ammonium phosphate cement composition |
| 07/08/2010 | US20100173845 Use of fertirelin and delta-endorphin as therapeutic agents |